PapalPower
- 19 May 2005 11:34




Main Web Site : www.henderson-morley.com
On line shop web site :
http://www.herpesexpert.com (Frost and Simpson)
Investor Relations email : investors@henderson-morley.com
Henderson Morley is a drug discovery company
The company has been developed specifically to carry out preliminary sourcing and screening of candidates to combat diseases caused by the herpes family of viruses and certain other DNA viruses
Latest GECR update 15th October 2006
Latest GE&CR update - 15th Oct 2006 :
The news investors have all been waiting for - regarding negotiations with a US dermatological pharmaceutical firm has finally been unveiled. The licence has been granted under an agreement to
Cutanea, a U.S. pharmaceutical company, specialising in the development of dermatology products in the US market.
The licence is for new applications of ICVT for the treatment of dermatological conditions in humans. The agreement and takes the form of an exclusive American, Mexican and Canadian wide licence to bring products to market through a programme of pre-clinical and clinical development of treatments either by Cutanea or through a sub-licence. Under the terms of the Agreement, Henderson Morley will receive up to 6.675 million dollars in development and commercialisation milestone payments up to the point at which the application receives regulatory approval, and will receive royalties on net sales thereafter.
Under its business plan, Henderson Morley has stated its belief that, following clinical development and regulatory licence approval, sales of the product in excess of $1.5 billion could be achieved over the subsequent ten year period. This would give a potential royalty to Henderson Morley in excess of $115 million over this term.
As a drug discovery company, it is imperative that Henderson continues to grant licenses to further develop its technology portfolio. This is the group's third ICVT license agreement. Encouragingly, Cutanea has a great management team with a proven track record of commercialising dermatology products.
Meanwhile, the company has announced that it has been working away on a vaccine against Koi Carp Herpes virus. The group believes it is now ready to start field trials of a
candidate vaccine, in a collaboration with the Internationally renowned Hagerman
Aquaculture Research Institute in Idaho USA. The initial immunogenicity studies should produce results within 6 months, enabling Henderson Morley scientists to optimise the vaccine formulation, with a view to securing a product licence from the veterinary authorities as soon as practicable.
Clearly activity at Henderson Morley has been significant in recent weeks. The licensing announcement is very encouraging, but with the news now out of the way, the shares have eased - a classic case of buy on the rumour, sell on the news. That said, the stock has now pulled back below the recent placing price. With so much going on at the company, further newsflow in the shorter term is far from unlikely.
*Henderson Morley is a corporate client of Bishopsgate Communications which is owned by RSH, the ultimate owner of GE&CR.
Forecasts and a formal recommendation are suspended ahead of the publication of a detailed note next month.
Harry6
- 12 Jan 2007 15:39
- 161 of 296
Cynic - On the 18th December you wrote about this company 'AVOID, though watch if you must' which sounds a bit like a retired schoolteacher who has spent a lifetime appearing knowledgeable to a bunch of 8 year olds.
What is it with you, why do you insist on posting negative stuff on a number of companies that you can't possibly have deep and detailed knowledge of?
I noticed you recently commented negatively on Party Gaming which subsequently rose by about a third, and now an almost 50% rise in the price of HM really tells us something meaningful about the quality of your investment advice.
Any other companies you hate at the moment?
capetown
- 12 Jan 2007 15:58
- 163 of 296
Harry cynic i find is very balanced on his comments,each to their own with hml i guess if you bought @6p his comments would have been valid.
Harry6
- 12 Jan 2007 16:12
- 164 of 296
Sorry Capetown, utter nonsense.
On 18th December the price was 1.6 - cynic made his above quoted comment - it is now 2.2, up 45%. Backhand down the line I think.
But that isn't the point. The question I asked is why does he insist on posting negative stuff and warnings to everybody on loads of stocks that he doesn't hold!
Driver - I'll have a deal with you; the next time cynic posts a big downer on a stock, let's buy it? What do you say, anyone else in?
capetown
- 12 Jan 2007 16:23
- 166 of 296
Harry6 i am celebrating the fact that for no reason other than a speculative one i bought 100 thou this am and i am very happy enjoy the ride
2517GEORGE
- 12 Jan 2007 16:26
- 167 of 296
I wonder, perhaps Tepnel Life (TED )
2517
Harry6
- 12 Jan 2007 16:50
- 168 of 296
Up 103% on the day.
For god's sake Cynic, get out of that Pub/Tea-Dance/Darby & Joan Club and give us some more of your gloom. There's people on here not even millionaires yet!
*quickly scans board for more Cynic posts*
capetown
- 12 Jan 2007 18:02
- 170 of 296
Driver do you think its too late to top up at these prices?
Haystack
- 12 Jan 2007 18:49
- 171 of 296
Beware concerning buying at these levels. HML does have a habit of rising as a result of deals, but when the details come out and it is clear that money is a long way off then it falls like a stone. Look what happened in September last year.
Harry6
- 12 Jan 2007 19:22
- 172 of 296
Are you Cynic in disguise,
are you Cynic in disguise...
Tonker
- 12 Jan 2007 19:42
- 173 of 296
I agree with haystack.... be careful buying at these levels, only buy if you can sell immediately..... You might be able to make a bit more, just don't leave your computer screen....!
Harry6
- 12 Jan 2007 20:07
- 174 of 296
Whooosshhhhh
Haystack
- 12 Jan 2007 20:30
- 175 of 296
None of the deals have had up front money. The only money expected short/medium term is for product development. Real revenue is usually years away. It may be a good punt if you want to hang on to them for a few years. Short term the rise may have taken place already.
Harry6
- 12 Jan 2007 23:44
- 178 of 296
Driver - interesting stuff, and thanks for that.
I bought some of these early last year and had a good profit in them until the terms of the deal were taken badly by the market back in September.
I was then looking at a loss, but I did some more work on the company and decided it was basically fine and that the fall was overdone, as most market movements seem to be these days, and bought some more to average down.
The price then fell again and I was looking at an even bigger loss, and I'd really put this one on the 2-5 year list, so I was pleasantly surprised when it all took off again today, and I'm now back in profit.
Question is, I'm off to Florence tomorrow until Wednesday - Christmas present from Mrs 6, top gift I thought - and so, do I put on a sell order for Monday morning, or do I run it and hope the price doesn't collapse again?
Incidentally, wasn't this one of ravydavygravy's tips? Anyone know what happened to him, he doesn't seem to post any more?
He was so well informed on the penny shares and he was always happy to share information.
Tonker
- 13 Jan 2007 14:53
- 180 of 296
Driver thanks for your quantitative opinions, I will be waiting and seeing, hope you are right....